FDA approves Boston Scientific drug-eluting stent
Mass High Tech
Boston Scientific Corp. has won FDA approval of its drug-eluting stent, the Promus Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, and plans to market it in the US immediately, the company said. ...
Boston Scientific Receives FDA Approval for PROMUS Element(TM) Plus Platinum ...MarketWatch (press release)
FDA clears Promus Element Plus stentCardiovascular Business
Boston Scientific Climbs After FDA ApprovalTradersHuddle.com
NASDAQ -Mass Device -Platinum today
all 114 news articles »